Board of directors of the Canadian Dupuytren Society

Cindy Andrew ICD.D
Chair of the Board


Cindy is a founding board member of the Canadian Dupuytren Society and current chair of the board.  Cindy is an Institute of Corporate Directors certified director (ICD.D) and serves several Boards with experience in corporate, not for profit and co-operative organizations.  Her over 25 years of Canadian and International experience include Operational Management as a CEO, Strategic Development and Planning, Business Development, Engineering, EPC/major project execution, and Mergers and Acquisitions. Cindy’s spouse developed Dupuytren’s disease (DD) several years ago and found it challenging to obtain a diagnosis and ascertain appropriate treatment options in Canada. Cindy traveled twice with her spouse to Europe and successfully received treatments for his hands.  He has since received treatments in Calgary for a related condition in his feet. Their experience, impassioned Cindy to connect with other DD individuals to work together to incorporate and commence the Canadian Dupuytren Society.

Paule Gauthier, CPA, CA, LL.M.
CEO of Canadian Dupuytren Society


Paule is a founding member of the Canadian Dupuytren Society and CEO of the CDS.     Paule has over 25 years of experience in Corporate and personal Taxation with a specialization in investments, in the context of Tax and Estate Planning mainly for business owners.   She holds a corporate governance training certification from the Institute for Governance of Private and Public Organizations. 

Paule has developed Dupuytren in 2012 and has often traveled to Europe to receive early treatments after unsuccessfully trying to gather relevant information on treatments available in Québec, Canada for early stages of the disease.   Her last treatments were given by the Hôpital Notre-Dame in 2017.    

Her quest for information was similar to that of many Canadians struggling with this condition and was at the root of her motivation for the creation of the Canadian Dupuytren Society.    With the help of other Canadians directors with similar motivations, brought together with the support of Wolfgang Wach of the International Dupuytren Society, she led the establishment of the Society in 2015 and its registration as a charity, the establishment of its Medical Advisory Board and the launch of the Society’s website. 

Bruce Pachkowski, CA, CBV, ICD.D


Bruce is a founding board member of the Canadian Dupuytren Society (“CDS”) and currently serves as Treasurer.  With more than 30 years of experience in the energy industry and private equity sector Bruce is currently a Principal with Trident Capital Partners and Chairman of the Board of Total Energy Services Inc.

In 2013 Bruce was diagnosed with Dupuytren’s disease and following unsuccessful attempts to treat the disease in its early stages in Canada he travelled to Europe and was successfully treated.  Subsequently Bruce developed a similar disease in his feet and again sought early stage treatment in Europe.  Bruce has worked diligently with other founding board members to structure and set-up the CDS allowing it to provide information about the disease and its treatment directly to Canadians.

Nathalie Fisette-Caza MBA, F. Pl. M. Tax, TEP


Nathalie joined the Canadian Dupuytren Society shortly after its inception in 2016 and has been its secretary since then. She has been working in financial institutions for over 20 years, providing tax, estate and succession planning services, with an expertise working with business owners. Nathalie is president of the Montreal Chapter of the Society of Trust and Estate Practitioners.

Nathalie felt especially concerned about the lack of information and resources available for people suffering from Dupuytren’s disease, since she has friends and family afflicted with chronic illnesses. It was thus only natural for her to help develop the Canadian Dupuytren Society.

David B. O’Gorman MSc., Ph.D.
Medical Advisory Board Coordinator


David is a founding member of the Canadian Dupuytren Society.   He received his doctoral degree from the School of Molecular Medicine at the University of Sydney, Australia, in 2001.

He has been an active Dupuytren Disease researcher for the last 15 years, specifically focussing on understanding the pathogenesis of this fibrosis.

David is an Associate Professor in the Schulich School of Medicine at the University of Western Ontario.

In parallel with his roles in the medical advisory board for the Canadian Dupuytren Society, David is also a member of the scientific committee of the International Dupuytren Society and one of the organising committee for the International Conference on Dupuytren Disease, hosted by Oxford University, London, England, in September 2021.

Mary Christidis


Mary is a founding member of the Canadian Dupuytren Society.   She  is a trained teacher, graduating from Niagara University Magna Cum Laude.   She joined Peel District School Board (PDSB) as a full time teacher of business and computer studies, ultimately becoming a curriculum head overseeing four program areas that included Health and Medical Technologies, Coop Education, Hospitality/ Food Services and Business Studies.

Mary has held positions on the boards of various volunteer organizations and has been on the Board of Directors for the Canadian Dupuytren’s Society since its inception.

Anne Vézina, B.Arch., MBA, ICD.D


Anne joined the Canadian Dupuytren Society’s Board of Directors in 2019. Building on her 25-year experience in the not-for-profit sector, Anne brings expertise in governance and accountability by translating strategic vision into execution and performance.

During her 18-year tenure with the Canadian Cancer Society, Anne held several senior leadership positions, including Acting President and CEO, when she played a key role in the development of the strategic plan and the restructuring of the nationwide organization. Anne obtained her ICD.D designation from the Institute of Corporate Directors in 2017 and volunteers in the charitable sector in Canada and in Belgium.

Last Updated: 11/09/2020